Cellegesic Draws Split Vote On Need For New Study On Anal Fissure Pain
Executive Summary
Cellegy's Cellegesic for anal fissures may or may not need a new study for approval following a split decision by FDA's Cardiovascular and Renal Drugs Advisory Committee at its April 25 meeting